12 Oct 2021

S-CellerateTM to IND

PDF 15.3 MB

The S-CellerateTM platform utilizes Samsung Biologics' breadth of knowledge gained through the Design of Experiments-based methodology to obtain optimal productivity in cell culture, the highest yield and quality in downstream processes, and the right safety and stability profile in formulation development

Content provided by our supplier

Samsung Biologics Co., Ltd.

  • KR
  • 2018
    On CPHI since
  • 1000 - 4999
Company types
Contract Service

Other Content from Samsung Biologics Co., Ltd. (18)